
MALI Platform
AI Stock Research
a16z Capital Management, L.L.C.: latest 13F holdings
For the quarter ending 30 September 2026, a16z Capital Management, L.L.C. reported 24 positions worth $19.9B in total, filed with the SEC on 16 November 2026. The quarter before, it reported $14.2B.
Read the filing at SEC EDGARChecked: the cover page's entry count and total value match the holdings table.
Top 24 positions by value
| # | Issuer | Class | Value | Weight | Shares | vs quarter before |
|---|---|---|---|---|---|---|
| 1 | SPACE EXPLORATION TECHN CORP | CLASS A COM STK | $18.4B | 92.35% | 121,777,808 | Added 62.7% |
| 2 | NAVAN INC | CL A | $592.3M | 2.98% | 28,218,676 | Unchanged |
| 3 | BRAVEHEART BIO INC | COM SHS | $206.7M | 1.04% | 10,232,420 | New |
| 4 | REVOLUTION MEDICINES INC | COM | $160.7M | 0.81% | 782,934 | Cut 15.0% |
| 5 | FREENOME INC | COMMON STOCK | $87.8M | 0.44% | 5,571,599 | New |
| 6 | NEUTRON HOLDINGS INC | COM | $80.3M | 0.40% | 2,849,097 | New |
| 7 | BLOCK INC | CL A | $74.8M | 0.38% | 1,016,697 | Unchanged |
| 8 | SCRIBE THERAPEUTICS INC | COM | $56.7M | 0.29% | 3,082,725 | New |
| 9 | FIGMA INC | CLASS A COM STK | $53.9M | 0.27% | 2,565,731 | Cut 57.1% |
| 10 | MAZE THERAPEUTICS INC | COM | $46.3M | 0.23% | 1,702,225 | Unchanged |
| 11 | STANDARD NUCLEAR INC | COM CL A | $34.5M | 0.17% | 2,924,890 | New |
| 12 | DAMORA THERAPEUTICS INC | COM NEW | $26.3M | 0.13% | 1,236,157 | Unchanged |
| 13 | BIOAGE LABS INC | COM | $22.9M | 0.12% | 3,233,170 | Unchanged |
| 14 | ERASCA INC | COM | $21.0M | 0.11% | 1,431,250 | Cut 50.0% |
| 15 | META PLATFORMS INC | CL A | $15.2M | 0.08% | 20,951 | Cut 90.1% |
| 16 | ROBLOX CORP | CL A | $11.6M | 0.06% | 274,570 | Unchanged |
| 17 | CAMP4 THERAPEUTICS CORP | COM | $8.6M | 0.04% | 2,125,339 | Unchanged |
| 18 | AKTIS ONCOLOGY INC | COM | $8.1M | 0.04% | 415,000 | Unchanged |
| 19 | BITGO HOLDINGS INC | COM SHS CL A | $4.9M | 0.02% | 666,356 | Unchanged |
| 20 | NAUTILUS BIOTECHNOLOGY INC | COM | $3.8M | 0.02% | 2,656,655 | Cut 70.7% |
| 21 | BLOSSOMHILL THERAPEUTICS INC | COM | $2.3M | 0.01% | 125,000 | New |
| 22 | KAILERA THERAPEUTICS INC | COMMON STOCK | $1.6M | 0.01% | 140,000 | Unchanged |
| 23 | GINKGO BIOWORKS HOLDINGS INC | CL A NEW | $1.4M | 0.01% | 108,568 | Unchanged |
| 24 | IP STRATEGY HOLDINGS INC | COM | $13.2K | 0.00% | 4,137 | Unchanged |
New this quarter
- BRAVEHEART BIO INC · $206.7M
- FREENOME INC · $87.8M
- NEUTRON HOLDINGS INC · $80.3M
- SCRIBE THERAPEUTICS INC · $56.7M
- STANDARD NUCLEAR INC · $34.5M
- BLOSSOMHILL THERAPEUTICS INC · $2.3M
Sold out
- OMADA HEALTH INC · was $25.3M
Reading a 13F
A 13F lists a manager's long positions in US-listed securities at the end of a quarter, filed up to 45 days later. It leaves out short positions, cash and most non-US holdings, so it is a partial, delayed view of a portfolio. Nothing here is investment advice.
Positions are named as the manager filed them. Values are the filing's own, in US dollars; changes compare share counts with the quarter before.